These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 35876170)
1. Identified potential biomarkers may predict primary nonresponse to infliximab in patients with ulcerative colitis. Zhang J; Wu X; Wei S; Liu C; Wang X; Dong W Autoimmunity; 2022 Dec; 55(8):538-548. PubMed ID: 35876170 [TBL] [Abstract][Full Text] [Related]
2. Identifying biomarkers associated with the diagnosis of ulcerative colitis via bioinformatics and machine learning. Wang Y; Huang J; Zhang J; Wang F; Tang X Math Biosci Eng; 2023 Apr; 20(6):10741-10756. PubMed ID: 37322958 [TBL] [Abstract][Full Text] [Related]
3. Genes associated with intestinal permeability in ulcerative colitis: changes in expression following infliximab therapy. Toedter G; Li K; Sague S; Ma K; Marano C; Macoritto M; Park J; Deehan R; Matthews A; Wu GD; Lewis JD; Arijs I; Rutgeerts P; Baribaud F Inflamm Bowel Dis; 2012 Aug; 18(8):1399-410. PubMed ID: 22223479 [TBL] [Abstract][Full Text] [Related]
4. SPP1 in infliximab resistant ulcerative colitis and associated colorectal cancer: an analysis of differentially expressed genes. Giannos P; Triantafyllidis KK; Giannos G; Kechagias KS Eur J Gastroenterol Hepatol; 2022 Jun; 34(6):598-606. PubMed ID: 35102110 [TBL] [Abstract][Full Text] [Related]
5. Construction of a molecular inflammatory predictive model with histone modification-related genes and identification of CAMK2D as a potential response signature to infliximab in ulcerative colitis. Ye S; Lyu Y; Chen L; Wang Y; He Y; Li Q; Tian L; Liu F; Wang X; Ai F Front Immunol; 2023; 14():1282136. PubMed ID: 38274809 [TBL] [Abstract][Full Text] [Related]
6. Focusing on non-responders to infliximab with ulcerative colitis, what can we do first and next? Pu D; Wang P; Wang X; Tian Y; Gong H; Ma X; Li M; Zhang D Int Immunopharmacol; 2024 Nov; 141():112943. PubMed ID: 39191122 [TBL] [Abstract][Full Text] [Related]
7. Biological characteristics of molecular subtypes of ulcerative colitis characterized by ferroptosis and neutrophil infiltration. Sun S; Mao Y; Le S; Zheng M; Li M; Chen Y; Chen J; Fan Y; Lv B Sci Rep; 2024 Apr; 14(1):9510. PubMed ID: 38664443 [TBL] [Abstract][Full Text] [Related]
8. Screening and experimental validation of diagnostic gene in ulcerative colitis with anti-TNF-α therapy. Chen Y; Li X; Sun R; Yang F; Tian W; Huang Q IUBMB Life; 2024 Jul; 76(7):451-463. PubMed ID: 38269750 [TBL] [Abstract][Full Text] [Related]
9. Identification of hub genes and immune infiltration in ulcerative colitis using bioinformatics. Hu W; Fang T; Zhou M; Chen X Sci Rep; 2023 Apr; 13(1):6039. PubMed ID: 37055495 [TBL] [Abstract][Full Text] [Related]
10. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine. Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138 [TBL] [Abstract][Full Text] [Related]
11. Identifying neutrophil-associated subtypes in ulcerative colitis and confirming neutrophils promote colitis-associated colorectal cancer. Zhang C; Zhang J; Zhang Y; Song Z; Bian J; Yi H; Ma Z Front Immunol; 2023; 14():1095098. PubMed ID: 36845139 [TBL] [Abstract][Full Text] [Related]
12. Identification of 6 cuproptosis-related genes for active ulcerative colitis with both diagnostic and therapeutic values. Zou M; Zhang W; Zhu Y; Xu Y Medicine (Baltimore); 2023 Oct; 102(43):e35503. PubMed ID: 37904461 [TBL] [Abstract][Full Text] [Related]
13. Revealing immune infiltrate characteristics and potential diagnostic value of immune-related genes in ulcerative colitis: An integrative genomic analysis. Huang J; Zhang J; Wang F; Zhang B; Tang X Front Public Health; 2022; 10():1003002. PubMed ID: 36388363 [TBL] [Abstract][Full Text] [Related]
14. Integrated Bioinformatics-Based Analysis of Hub Genes and the Mechanism of Immune Infiltration Associated With Acute Myocardial Infarction. Wu Y; Jiang T; Hua J; Xiong Z; Chen H; Li L; Peng J; Xiong W Front Cardiovasc Med; 2022; 9():831605. PubMed ID: 35463752 [TBL] [Abstract][Full Text] [Related]
15. Identification of differentially expressed genes in ulcerative colitis and verification in a colitis mouse model by bioinformatics analyses. Shi L; Han X; Li JX; Liao YT; Kou FS; Wang ZB; Shi R; Zhao XJ; Sun ZM; Hao Y World J Gastroenterol; 2020 Oct; 26(39):5983-5996. PubMed ID: 33132649 [TBL] [Abstract][Full Text] [Related]
16. Prediction and Verification of Potential Therapeutic Targets for Non-Responders to Infliximab in Ulcerative Colitis. Lyu X; Zhang Z; Liu X; Geng L; Zhang M; Feng B J Inflamm Res; 2023; 16():2063-2078. PubMed ID: 37215377 [TBL] [Abstract][Full Text] [Related]
17. Identification of Potential Biomarkers and Immune Infiltration Characteristics in Ulcerative Colitis by Combining Results from Two Machine Learning Algorithms. Bu M; Cao X; Zhou B Comput Math Methods Med; 2022; 2022():5412627. PubMed ID: 35959356 [TBL] [Abstract][Full Text] [Related]
18. Identifying Hub Genes, Key Pathways and Immune Cell Infiltration Characteristics in Pediatric and Adult Ulcerative Colitis by Integrated Bioinformatic Analysis. Xiu MX; Liu YM; Chen GY; Hu C; Kuang BH Dig Dis Sci; 2021 Sep; 66(9):3002-3014. PubMed ID: 32974809 [TBL] [Abstract][Full Text] [Related]
19. Identification of Common Differentially Expressed Genes and Potential Therapeutic Targets in Ulcerative Colitis and Rheumatoid Arthritis. Chen Y; Li H; Lai L; Feng Q; Shen J Front Genet; 2020; 11():572194. PubMed ID: 33262784 [TBL] [Abstract][Full Text] [Related]
20. Identified S100A9 as a target for diagnosis and treatment of ulcerative colitis by bioinformatics analysis. Tan L; Li X; Qin H; Zhang Q; Wang J; Chen T; Zhang C; Zhang X; Tan Y Sci Rep; 2024 Mar; 14(1):5517. PubMed ID: 38448514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]